Fresenius SE & Co. (OTCMKTS:FSNUY) Share Price Passes Below Fifty Day Moving Average – Should You Sell?

Posted by Linda Flegge on May 21st, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $12.57 and traded as low as $11.58. Fresenius SE & Co. shares last traded at $11.83, with a volume of 72,340 shares.

Wall Street Analysts Forecast Growth

FSNUY has been the topic of a number of recent research reports. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy”.

Read Our Latest Stock Analysis on Fresenius SE & Co.

Fresenius SE & Co. Stock Performance

The stock has a market capitalization of $26.65 billion, a P/E ratio of 15.77 and a beta of 0.68. The company’s 50-day moving average is $12.57 and its two-hundred day moving average is $13.85. The company has a current ratio of 1.32, a quick ratio of 1.00 and a debt-to-equity ratio of 0.47.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $6.75 billion during the quarter, compared to the consensus estimate of $6.79 billion. Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.29%. As a group, sell-side analysts anticipate that Fresenius SE & Co. will post 1.05 EPS for the current fiscal year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.